Dr Robert Rothbaum, MD

Dr. Sofia Verstraete, MD, is a pediatric gastroenterologist based in San Francisco, specializing in inflammatory bowel disease (IBD) in children, including ulcerative colitis and Crohn's disease. As the co-director of the Pediatric Inflammatory Bowel Disease Program at UCSF Benioff Children's Hospital, she is dedicated to advancing patient care through clinical research and quality improvement initiatives. With a strong commitment to diversity, Dr. Verstraete offers care in both English and Spanish, addressing the needs of medically complex cases. Her research focuses on the classification of IBD in pediatric patients and the impact of ethnicity on disease characteristics, while she actively participates in clinical trials for cutting-edge medications in pediatric IBD. Generated from the website

Dr. Robert E. Goldsby, MD is a highly respected pediatric cancer specialist and the director of the UCSF Survivors of Childhood Cancer Program at UCSF Benioff Children's Hospitals in San Francisco, CA. With a focus on high-risk sarcomas, Dr. Goldsby provides exceptional care and long-term follow-up for patients who had cancer in childhood, earning him numerous awards and grants for his groundbreaking work. As a pediatric hematologist-oncologist and bone marrow transplant specialist, Dr. Goldsby is dedicated to delivering world-class care to children and young adults with a wide range of conditions, from common to rare. With a commitment to excellence and a passion for improving patient outcomes, he is ranked as one of the best in Northern CA for pediatric cancer, heart surgery, cardiology, and more.Generated from the website

The UCSF Pediatric Brain Tumor Program offers advanced treatments for brain and spinal cord tumors in a supportive environment, striving to cure whenever possible while ensuring the best possible care and quality of life for patients. Their highly experienced team of specialists collaborates to deliver accurate diagnoses and effective treatment plans, addressing the emotional and psychological health of each child and their family. Committed to innovative care, the program utilizes cutting-edge diagnostic methods and treatment technologies, including minimally invasive techniques and targeted therapies. Involvement in national alliances for brain tumor research ensures that patients have access to promising experimental therapies and clinical trials, contributing to the advancement of pediatric neuro-oncology. Generated from the website